Leukotriene modifier therapy for mild sleep-disordered breathing in children

Keyphrases

• Sleep-disordered Breathing 100%
• Leukotriene Modifiers 100%
• Protein Expression 40%
• Obstructive Sleep Apnea 40%
• Leukotriene B4 (LTB4) 40%
• Adenoid Tissue 40%
• Montelukast 40%
• Adenotonsillectomy 40%
• LTC4 40%
• Adenoid Size 40%
• Gene Expression 20%
• Therapeutic Potential 20%
• Therapeutic Intervention 20%
• Intervention Studies 20%
• Sleep Study 20%
• Quantitative PCR 20%
• Immunohistochemistry 20%
• Neurocognitive 20%
• Tonsillar Tissue 20%
• Leukotriene Receptor 20%
• Throat Infection 20%
• Western Blotting 20%
• Size Estimates 20%
• Sleep Disturbance 20%
• Double-blind Placebo-controlled Trial 20%
• Oral Therapy 20%
• R Protein 20%
• Lateral X-ray 20%
• X-ray Film 20%
• Alternative Therapeutics 20%

Medicine and Dentistry

• Obstructive Sleep Apnea 100%
• Leukotriene 100%
• Sleep-Disordered Breathing in Children 100%
• Protein Expression 33%
• Adenotonsillectomy 33%
• Montelukast 33%
• Placebo 16%
• Gene Expression 16%
• Patient Referral 16%
• Intervention Study 16%
• Sleep Studies 16%
• Western Blot 16%
• Breathing 16%
• Real-Time Polymerase Chain Reaction 16%
• Immunohistochemistry 16%
• Neck 16%
• Leukotriene Receptor 16%
• Pharyngitis 16%
• Sleep Disorder 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Sleep Disordered Breathing 100%
• Montelukast 28%
• Western Blot 14%
• Placebo 14%
• Sleep Studies 14%
• Pharyngitis 14%
• Leukotriene Receptor 14%
• Sleep Disorder 14%
• Intervention Study 14%